Clinical Trial Update: DAISe 1 Feasibility Study to Evaluate the DAISe Thrombectomy System for Acute Ischemic Stroke [NA]

View source ↗

Summary

A clinical trial update indicates the DAISe 1 Feasibility Study evaluating the DAISe Thrombectomy System for acute ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• DAISe Thrombectomy System

Snippet

Sponsor: MIVI Neuroscience, Inc. | Conditions: Acute Ischemic Stroke | NA | Status: TERMINATED